[CAS NO. 2248127-53-7] Ecubectedin

Ships within

Stock

Price

Qty

Total

$0.00

Please click "REQUEST A QUOTE" button if you need other sizes or custom synthesis

request a quote

If there is no stock, or you need other sizes or custom synthesis, please:

PRODUCTS SPECIFICATIONS [2248127-53-7]

Catalog

HY-139570

Brand

MCE

CAS

2248127-53-7

DESCRIPTION [2248127-53-7]

Overview

MDL	-
Molecular Weight	784.87
Molecular Formula	C41H44N4O10S
SMILES	O[C@@H]([C@]1([H])CC2=CC(C)=C3OC)N([C@](COC4=O)([H])C5=C(OCO6)C6=C7C)[C@@]([C@@](N1C)([H])C2=C3O)([H])[C@@](SC[C@@]4(N[C@@H]8CO)C9=C(C8)C%10=CC=CC=C%10N9)([H])C5=C7OC(C)=O

For research use only. We do not sell to patients.

Summary

Ecubectedin (PM14) is a derivative. Ecteinascidins is a family of tetrahydroisoquinoline alkaloids with wide range of antitumor and antimicrobial activities ^[1] .

Clinical Trial

NCT Number	Sponsor	Condition	Start Date	Phase
NCT05076396	PharmaMar	Advanced Solid Tumor	September 6, 2017	Phase 1
NCT05146440	Grupo Espanol de Investigacion en Sarcomas	Advanced Soft-tissue Sarcoma\|Advanced L-sarcomas\|Other Advanced Sarcomas\|Advanced Solid Tumor\|Localized Soft-tissue Sarcoma	November 23, 2021	Phase 1\|Phase 2

Shipping

Room temperature in continental US; may vary elsewhere.

Storage

Please store the product under the recommended conditions in the Certificate of Analysis.